MUSCLE-INVASIVE UROTHELIAL CARCINOMA
Clinical trials for MUSCLE-INVASIVE UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MUSCLE-INVASIVE UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for MUSCLE-INVASIVE UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized vaccine + immunotherapy aims to stop bladder cancer return
Disease control Recruiting nowThis phase 2 trial tests whether adding a personalized cancer vaccine (autogene cevumeran) to the immunotherapy drug nivolumab can prevent high-risk bladder cancer from coming back after surgery. About 62 participants will receive either the combination or nivolumab alone. The st…
Matched conditions: MUSCLE-INVASIVE UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New drug cocktail aims to control bladder cancer before surgery
Disease control Recruiting nowThis early-phase trial is testing whether a combination of two drugs, atezolizumab and tiragolumab, can help control bladder cancer when given before surgery to remove the bladder and tumor. The study includes 10 adults with muscle-invasive bladder cancer who cannot take standard…
Matched conditions: MUSCLE-INVASIVE UROTHELIAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New study aims to uncover nerve side effects of cancer drug
Knowledge-focused Recruiting nowThis study looks at how the drug enfortumab vedotin affects nerves in people with advanced or muscle-invasive bladder cancer. Researchers will use nerve tests and patient surveys to track changes over 9-15 weeks. The goal is to better understand and potentially reduce nerve damag…
Matched conditions: MUSCLE-INVASIVE UROTHELIAL CARCINOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC